A modified adrenal gland-sparing surgery based on retroperitoneal laparoscopic radical nephrectomy by Zhenyu Xu et al.
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Xu et al. World Journal of Surgical Oncology 2014, 12:179
http://www.wjso.com/content/12/1/179RESEARCH Open AccessA modified adrenal gland-sparing surgery
based on retroperitoneal laparoscopic radical
nephrectomy
Zhenyu Xu, Zhengyu Zhang, Jianping Gao, Zhifeng Wei, Xiaofeng Xu, Jie Dong, Hao Tang, Xiaoming Yi,
Chaopeng Tang and Wenquan Zhou*Abstract
Background: The objective of this study was to modify the adrenal gland-sparing strategy based on retroperitoneal
laparoscopic radical nephrectomy by reviewing the anatomic relationship between the kidney and the adrenal gland.
Methods: From June 2010 to October 2012, a total of 68 patients (45 males and 23 females) with localized renal cell
carcinoma were treated at our hospital. The study included 35 cases that were right side and 33 cases that were left,
and average patient age was 54.06 years. The average tumor size was 4.7 cm. Tumors were classified via the TNM
staging system. All patients underwent adrenal gland-sparing surgery based on retroperitoneal laparoscopic radical
nephrectomy.
Results: For each patient, surgery was successful without conversion to open surgery. The average operative time was
56.65 ± 26.60 min, and the mean blood loss was 70.61 ± 60.96 ml. All patients were discharged from the hospital 3 to
8 days after surgery. During surgery, the adrenal gland was slightly lacerated in three cases and the peritoneum
showed perforation in six cases. Only one case recurred during the study follow-up.
Conclusions: Based on retroperitoneal laparoscopy radical nephrectomy, this effective adrenal gland-sparing surgery
showed direct exposure of tissue and little interference of the upper pole of the kidney. Elevation of the adrenal gland
could help with the complete dissection of the adrenal gland from the kidney. The separation of the kidney was rapid,
simple and accurate. The probability of adrenal gland damage was reduced. This strategy is recommended for
widespread use in T1-2 renal neoplasms.
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Renal cell carcinoma (RCC), accounting for 3% of adult
solid tumors, is mostly detected in patients 50 to 70
years old [1]. Fortunately, due to the development of im-
aging modalities such as ultrasound, computed tomog-
raphy (CT) and magnetic resonance imaging (MRI),
most of these kidney masses can be detected at an early
stage and can be cured by surgery [2,3]. Currently, retro-
peritoneal laparoscopic radical nephrectomy is suggested
as the best therapy for early stage RCC [4].
In recent years, laparoscopic radical nephrectomy (LRN)
has been widely used, and the number of reports of* Correspondence: shzwqzsl@163.com
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unless otherwise stated.complications involved in surgery is rising [5,6]. Briefly,
compared with open radical nephrectomy, LRN is associ-
ated with a smaller incision; less blood loss, narcotic re-
quirement and complications; shorter hospital stay; and
earlier resumption of routine activities [7]. The technical
progress of laparoscopic surgery for RCC has been re-
markable. Laparoscopic partial nephrectomy (LPN) is also
widely used, having advantages that include decreased
bleeding and speedy recovery [8]. This therapeutic sche-
dule is suitable for patients with only one functional kidney
[9]. However, a previous study showed that LRN was su-
perior to LPN because of the lower incidence of complica-
tions and higher survivability [10]. In this study, LRN was
suitable and chosen for all patients. The retroperitoneal
laparoscopic approach to the kidney offered minimallyThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[11]. Over the last two decades, all renal surgeries have
been shown to be feasible when incorporating this tech-
nique. However, this method can include complicated
procedures, such as a donor nephrectomy and radical
nephroureterectomy, and has developed a number of
modifications to make surgery easier and cost effective
[12,13]. For the detection of small tumors with less lymph
node and adrenal gland involvement [3], there was a ten-
dency to perfect a retroperitoneal laparoscopic ap-
proach, which has been proposed as suitable for kidney
tumors.
Although some researchers have suggested that adre-
nalectomy should be performed as an integral part of
the surgery [14], modern cases have not shown a benefit
to routinely removing the adrenal gland with radical
nephrectomy, and the incidence rate of adrenal metasta-
sis is low [15]. In humans, the right adrenal gland is tri-
angular shaped, while the left adrenal gland is semilunar
shaped. The adrenal glands affect kidney function
through the secretion of aldosterone. Metastasis of RCC
to the contralateral adrenal gland is very rare and ad-
renal metastasis is rarely diagnosed during life [16]. The
ipsilateral adrenalectomy during radical or partial neph-
rectomy does not improve survival; moreover, Brian et al.
found that there was no significant difference in survival
rate between patients with and without adrenalectomy
[17]. Adrenal gland-sparing surgery is usually accompan-
ied by adrenal gland tears, which may be due to the separ-
ation of the adrenal gland from the kidney. No study has
been published on adrenal gland-sparing during retroperi-
toneal laparoscopic radical nephrectomy.
In the present study, the anatomic relationship between
the kidney and adrenal gland was reviewed, and a modi-
fied adrenal gland-sparing surgery was explored based on
retroperitoneal laparoscopic radical nephrectomy for
patients who did not need to have their adrenal gland
removed.
Methods
Our study was approved by the Ethics Committee of
Jinling Hospital, Medical School of Nanjing University,
Nanjing, China. Written informed consent was obtained
from all patients.
Clinical information
From June 2010 to October 2012, a total of 68 patients
suffering from localized RCC were treated at our hos-
pital, including 45 male and 23 female cases, and their
average age was 54.06 years. The mean tumor size was
4.7 cm (range, 1.6 to 8.0 cm). Preoperative CT examin-
ation excluded local lymph nodes and distant metastasis.
The stage for RCC was recorded based on the 2010 7th
edition of the American Joint Committee on Cancer(AJCC) TNM staging system [18]. Of the 68 tumors, 57
tumors were pathologic stage T1 and 11 were stage T2.
Examination with intraudio videoenous urography (IVU)
and emission computed tomography (ECT) verified nor-
mal function of the contralateral kidney. If the tumor
was located in the lower-middle part of kidney or was a
small renal carcinoma, adrenal gland-sparing was needed.
Patients with a large tumor or with lymph node or distal
metastases were excluded from our study.
Operative techniques
Establishment of retroperitoneal space
Patients were administered general anesthesia via tra-
cheal intubation and were placed in a lateral position in
order to elevate the kidney. A mid-axillary line incision
was made at two transverse fingers above the crista iliaca.
A 10-mm trocar puncture was directed through the inci-
sion, pushing the peritoneum ventrally. A lactoprene bal-
loon was placed, injected with 300 ml air (maintained 5
min), and then removed. The 5-mm and 10-mm trocars
were inserted in the subcostal incision on the anterior and
posterior axillary lines, respectively. Then, CO2 was
injected into the retroperitoneum to establish a retro-
peritoneal space (air pressure: 12 to 15 mm Hg), and
the corresponding surgical instruments were placed.
For obese patients, extraperitoneal adipose tissues were
resected using the ultrasonic scalpel to facilitate operation.
Dissection of kidney
The dissection was performed along the anterior surface
of the psoas muscle and fascia to access the connective
tissue platform, which can help to provide adequate spa-
cing. The posterior surface of Gerota’s fascia was
opened close to the diaphragm to expose the fatty tissue
harboring renal vessels. The renal artery was bluntly
separated via aspirator and angle clamps and was clipped
with Hem-O-Lock. After the structure of the renal vein
and the color of kidney were examined, the parenchyma
was dissociated to confirm there was no ectopic artery.
Then the renal vein was ligated with Hem-O-Lock and
the blood flow was blocked.
Adrenal gland-sparing surgery
The adrenal gland-sparing surgery of a tumor located on
the left kidney (Figure 1A-F) was similar to that for a
tumor on the right side (Figure 1G-K).
After disconnection of the renal pedicle vessels, the in-
terior surface of the perirenal fascia was mobilized from
the interior side of the renal hilum and the undersurface
of the adrenal gland (Figure 1A,G). After cutting the
renal hilum vessels, the adrenal gland was elevated to 1
to 2 cm and was kept with a sufficient tension to provide
adequate space. The bottom of the adrenal gland was
dissociated along the edge of the renal parenchyma from
Figure 1 Radical resection of renal carcinoma located on left side and right side. A-F represents surgery to the left side. G-L represents
surgery to the right side. A and G. Dissection of the interior side of the renal hilum toward the perirenal fascia. B and H. Dissection of the bottom
of adrenal gland toward the perirenal fascia. C and I. Dissection of the upper pole of the kidney. D and J. Dissection of the kidney from adrenal
gland. E and K. Complete separation of the kidney from the adrenal gland. F and L. A relatively intact adrenal gland. a. The upper pole of the
kidney. b. The perirenal fascia. c. The adrenal gland. d. The renal pedicle.
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until the interior pole of the adrenal gland was mobilized
(Figure 1C,I). To separate the kidney from the adrenal
gland, the dissociation must be close to the perirenal
fascia. The inner side of the kidney was further mobilized
along the lateral branch of the adrenal gland (Figure 1D,J).
The kidney was further mobilized from the perirenal
fascia (Figure 1E,K) and completely divided from the
parenchyma (Figure 1F,L). The incised kidney and sur-
rounding tissues were placed into the extraction bag.
The fascia was closed with interrupted sutures, and the
skin incision was closed with buried suture after a drain
tube was placed.
A model diagram figuratively shows the procedure of
the adrenal gland-sparing surgery (Figure 2).Postoperative therapy
Antibiotics were administered 1 to 2 days after surgery
to prevent infection. The drain tube was removed 1 to 3
d after surgery. For patients with RCC confirmed via
postoperative pathology, interferon plus interleukin im-
munotherapy was administered.Figure 2 A model diagram of the adrenal gland-sparing surgery
on a right kidney. I: The anatomic relationship between the kidney
and the adrenal gland; II: Division of the artery and the vein; III:
Separation of the kidney from the adrenal gland; IV: The intact
adrenal gland and the removed kidney. A, artery; V, vein; U, ureter.Follow-up study
Patients were reexamined at 3, 6, and 12 months after
surgery. Then, all cases were required to recheck once a
year. The examination index included routine blood and
Table 1 Clinical information of 68 patients with local
renal carcinoma
Patient demographics (n = 68, mean ± standard deviation)
Gender (Male/Female) 45/23
Tumor location (right/left) 35/33
Age (years) 54.06 ± 13.34
Tumor Size (cm) 4.7 ± 1.35
Operation time (min) 56.65 ± 26.60
Blood loss (ml) 70.61 ± 60.96
Time for dieting (h) 27.78 ± 9.26
Time of getting out of bed (h) 31.57 ± 8.79
Hemoglobin (g/l)
Preoperative hemoglobin 130.38 ± 12.96
Postoperative hemoglobin 118.88 ± 12.86
Serum creatinine (μmol/l)
Preoperative serum creatinine 75.47 ± 19.32
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and abdomen B ultrasonography and CT examination.
Results
Clinical characteristics
All patients were successfully operated without conversion
to open surgery. The surgical procedure was shown in Fig-
ure 1 and Figure 2. The average operative time was 56.65
min (range, 28 to 164 min), and the average estimated
bleeding was 70.61 ml (range, 15 to 300 mL). The mean
serum creatinine level was 75.47 μmol/l before operation
and 94.57 μmol/l after operation. The recovery eating time
ranged from 15 to 65 h. Patients were allowed to get out of
bed 13 to 60 h after the operation and were discharged to
home at 3 to 8 d after operation.
However, in six cases, the peritoneum was perforated
and treated with laparoscopic suturing technique during
the surgery. Additionally, in three cases, the torn edges
of the lateral branch of the adrenal gland were effectively
treated with bipolar coagulation hemostasis. No other
complication was identified.
Pathology
Of the 68 tumors, 57 tumors were pathologic stage T1
and 11 were stage T2. Histological analysis of the 68
specimens revealed 61 clear cell tumors, three papil-
lary tumors, one chromophobe tumor, one spindle-cell
tumor, one myogenic tumor and one tumor related to
Xp11.2 translocation/TFE3 gene fusion (Table 1).
Follow-up study
All patients received injections of interferon plus inter-
leukin for 3 to 6 months after operation. The average
follow-up was 18 months (range, 3 to 26 months). Only
one case showed lesions on the lateral peritoneum and
was further treated via chemotherapy. No local recur-
rence or distant metastasis was visible via ultrasound
and chest X-ray examination, which might be due to the
early pathologic stage of all tumors and the short follow-
up period. CT examination of one patient with clear cell
tumor is shown in Figure 3.
Discussion
With the growing number of incidentally diagnosed kid-
ney neoplasms, significant advances in the treatment of
RCC have been developed during the last 20 years [19].
LRN has been suggested as a safe and effective treatment
for renal tumors and has been safely performed for large
right-sided T2 tumors [20]. Retroperitoneoscopic LRN
surgery must be performed in a narrow operative space
and is technically difficult to perform [12]. In recent years,
retroperitoneoscopic surgery has been widely used, based
on the invention of atraumatic balloon dilation that makes
it easy to secure a space [6,21].Many reports have presented results of comparisons of
retroperitoneoscopic surgery with other traditional surgical
methods, which have suggested significant technical im-
provements in retroperitoneoscopic surgery [22,23]. How-
ever, the procedure of retroperitoneoscopic surgery,
where the main step is the management of the renal
pedicle and the adrenal gland, is controversial and
needs to improve [24,25]. During the surgery, adrenal
gland-sparing is necessary in many cases, such as when
tumors are located in the lower-middle part of the kidney,
and for small RCC and renal pelvic tumors [26]. Al-
though adrenal gland-sparing is easier than adrenalec-
tomy, lacerations of the adrenal gland usually occurred
due to the complex inner structure and even led to wound
errhysis or delayed hemorrhage [27]. No reports discussed
the adrenal gland-sparing surgery based on LRN and the
proper surgery to completely retain the adrenal gland.
In this study, we reviewed the anatomic relationship
between the kidney and adrenal gland and discussed a
modified adrenal gland-sparing strategy based on retro-
peritoneal laparoscopic radical nephrectomy. Briefly, the
vessels of the renal pedicle were separated; the interior
Figure 3 Computed Tomography (CT) examination of a
43-year-old male with left renal carcinoma. A. CT imaging at the
postoperative check indicated the size, location and integrality of
the left adrenal gland. B. CT imaging at the preoperative examination
showed the relationship between the left kidney and the left adrenal
gland. C. The preoperative CT imaging displayed the location and size
of the tumor.
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terior side of the renal hilum and the undersurface of the
adrenal gland; the adrenal gland was elevated and was
kept at a sufficient tension to provide adequate space; the
bottom of the adrenal gland was dissociated along the
edge of the renal parenchyma; and the kidney was sepa-
rated from the adrenal gland.
Compared to the traditional process, our adrenal gland-
sparing surgery was directly performed on a horizontal
plane. The dissection of the adrenal gland from the perire-
nal fat could reduce the influence of the upper pole of the
kidney and the incidence of lacerations or partial resection
of the adrenal gland. The upper pole of the kidney could
be lifted after separation of the renal pedicle vessels, which
could change the tension between the adrenal gland and
the kidney and facilitate the dissection of the kidney from
the adrenal gland. Other characteristics of our procedure
included a small incision of dissection, clear and fixed
anatomy, less influence of fat tissues and less variation.
Although the main approach for a left kidney tumor
was similar to the right, there were several anatomic
differences [28]. For example, the right adrenal central
vein converged with the inferior vena cava, while the
left adrenal central vein converged into the left renal
vein. For the left kidney, dissection must be performed
along with the renal pedicle to avoid damage to the leftadrenal gland. Furthermore, Dieter et al. found that it
is beneficial to improve survival by using adjuvant
treatment with inhibitors of VEGF-R and mTOR after
nephrectomy [29]. Similarly, adjuvant treatment in pa-
tients with interferon and interleukin seems to be
beneficial and can be considered for administration
during the postoperative recovery process.
Conclusions
In conclusion, adrenal gland-sparing surgery was per-
formed on 68 patients with T1-2 RCC. During the sur-
gery, the peritoneum was perforated in six cases and
impaired in three cases. No other complication was
identified. Follow-up study showed only one reoccur-
rence, which was lon the lateral peritoneum. No distant
metastasis was visible. This procedure offered smaller
incision, shorter operative time and greater outcomes
than traditional retroperitoneoscopic surgery. While
this study demonstrated that adrenal gland-sparing sur-
gery was a feasible option for small renal masses, its
limitations should be stressed. Careful patient and
tumor selection criteria should be applied. To further
document these results, studies with longer follow-up
and other TNM stages are needed.
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